Vimta Labs Ltd

Vimta Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vimta Labs Ltd

₹ 1,089 -5.54%
25 Apr - close price
vimta.com BSE: 524394 NSE: VIMTALABS
About

Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider[1]

Key Points

Business Overview:[1]
VLL is is in the business of contract research and testing in the fields of biologics, small molecules, agro -chemicals, food & beverages, electronics, clinical diagnostics, medical devices, home and personal care products, and environment testing

Website BSE NSE
  • Market Cap ₹ 2,422 Cr.
  • Current Price ₹ 1,089
  • High / Low ₹ 1,183 / 420
  • Stock P/E 39.8
  • Book Value ₹ 154
  • Dividend Yield 0.18 %
  • ROCE 17.6 %
  • ROE 13.5 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 7.06 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Miscellaneous

Part of BSE Healthcare BSE Allcap BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
67 74 79 80 77 82 83 66 75 80 75 85 90
47 51 55 54 56 58 59 48 51 55 49 55 57
Operating Profit 21 23 24 25 21 24 25 17 24 24 26 30 33
OPM % 31% 31% 30% 32% 28% 30% 30% 27% 32% 31% 35% 35% 37%
1 0 1 1 1 1 1 0 -1 0 -1 -1 5
Interest 0 1 1 1 1 0 0 1 1 1 0 0 1
Depreciation 6 7 7 8 8 8 8 9 8 8 8 8 10
Profit before tax 15 16 17 18 14 17 16 8 14 16 17 20 28
Tax % 25% 27% 28% 26% 27% 23% 25% 25% 25% 24% 26% 24% 23%
12 12 12 13 10 13 12 6 10 12 12 15 22
EPS in Rs 5.28 5.35 5.45 5.98 4.63 5.73 5.51 2.86 4.57 5.57 5.54 6.88 9.68
Raw PDF
Upcoming result date: tomorrow

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
181 211 278 318 318 329
151 158 198 223 231 216
Operating Profit 30 53 80 95 87 113
OPM % 17% 25% 29% 30% 27% 34%
3 1 0 3 4 4
Interest 4 2 2 3 2 2
Depreciation 21 23 23 31 34 34
Profit before tax 8 29 56 65 54 81
Tax % 17% 25% 26% 26% 25%
7 21 41 48 41 61
EPS in Rs 3.10 9.68 18.69 21.77 18.50 27.67
Dividend Payout % 0% 21% 11% 9% 11%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 15%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 24%
TTM: 34%
Stock Price CAGR
10 Years: 32%
5 Years: 69%
3 Years: 44%
1 Year: 101%
Return on Equity
10 Years: %
5 Years: %
3 Years: 17%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4 4 4 4 4 4
Reserves 168 190 230 277 315 338
33 30 19 15 19 12
40 50 54 65 61 86
Total Liabilities 246 274 307 362 400 440
138 135 169 175 171 183
CWIP 2 17 0 12 59 75
Investments 0 0 0 0 0 0
106 122 138 175 170 183
Total Assets 246 274 307 362 400 440

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
24 37 59 88 61
-21 -32 -38 -57 -76
-1 -5 -17 -11 -2
Net Cash Flow 3 1 5 20 -17

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 117 127 101 92 100
Inventory Days 191 140 115 187 185
Days Payable 117 142 82 119 62
Cash Conversion Cycle 191 125 134 159 223
Working Capital Days 100 114 94 82 101
ROCE % 14% 24% 25% 18%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
37.46% 37.46% 37.26% 37.25% 37.23% 37.00% 36.98% 36.92% 36.89% 36.89% 36.76% 36.70%
0.35% 0.49% 2.28% 2.25% 2.72% 2.74% 2.88% 5.13% 5.16% 3.31% 3.81% 3.66%
2.01% 2.04% 2.13% 2.14% 2.14% 1.50% 1.49% 1.50% 1.49% 0.00% 1.15% 1.43%
60.18% 60.02% 58.35% 58.37% 57.92% 58.75% 58.65% 56.45% 56.45% 59.80% 58.28% 58.20%
No. of Shareholders 18,10618,28318,91617,16217,43918,42919,95718,55019,05420,11421,15626,183

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls